CE Introduction The last 5 years have been an exciting time to be involved in aphasia treatment research. This, at least, has been my perception. However, I decided that I needed some “evidence” to support this statement and proceeded with an informal and not very scientific approach to finding some confirmatory ... SIG News
SIG News  |   April 01, 2008
CE Introduction
Author Affiliations & Notes
  • Leora R. Cherney
    Center for Aphasia Research, Rehabilitation Institute of Chicago, Chicago, IL
Article Information
SIG News
SIG News   |   April 01, 2008
CE Introduction
SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, April 2008, Vol. 18, 4-5. doi:10.1044/nnsld18.1.4
SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, April 2008, Vol. 18, 4-5. doi:10.1044/nnsld18.1.4
The last 5 years have been an exciting time to be involved in aphasia treatment research. This, at least, has been my perception. However, I decided that I needed some “evidence” to support this statement and proceeded with an informal and not very scientific approach to finding some confirmatory data. I began with a quick search of http://www.clinicaltrials.gov/. Using the search term aphasia followed by careful review of the study abstracts, eleven trials directly assessing an intervention for aphasia were found. These included several drug studies (e.g., for donepezil; levodopa; memantine; kepra - levetiracetam), behavioral studies (e.g., constraint induced language therapy; response elaboration training; semantic feature training) and a study of an investigational device that provides cortical electrical stimulation.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
Become a SIG Affiliate
Pay Per View
Entire SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders content & archive
24-hour access
This Issue
24-hour access
This Article
24-hour access
We've Changed Our Publication Model...
The 19 individual SIG Perspectives publications have been relaunched as the new, all-in-one Perspectives of the ASHA Special Interest Groups.